PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Novel bioactive peptides promote wound healing in vivo

2012-02-27
(Press-News.org) BOSTON (February 23, 2012, 5:00 pm ET) — Researchers have combined bioactive peptides to successfully stimulate wound healing. The in vitro and in vivo study, published today in PLoS ONE, demonstrates that the combination of two peptides stimulates the growth of blood vessels and promotes re-growth of tissue. Further development of these peptides could lead to a new treatment for chronic and acute wounds.

The team tested a newly-created peptide, UN3, in pre-clinical models aimed to simulate impaired wound healing as is seen in patients with peripheral vascular diseases or uncontrolled diabetes. The peptide led to a 50% increase in blood vessel wall development, a 250% increase in growth of blood vessels, and a 300% increase in cell migration in response to the injury.

"Using double-blinded in vivo experiments, we then applied the wound-healing peptide UN3 with a peptide created during a previous study, named comb1. We found that, together, the two out-performed all control groups, including the only FDA-approved growth factor-containing drug for treating diabetic wounds, becaplermin," said first author, Tatiana Demidova-Rice, PhD, now a graduate of the cell, molecular and developmental biology program at the Sackler School of Graduate Biomedical Sciences.

In December 2010, Herman and Demidova-Rice identified several peptides from a Clostridium histolyticum collagenase treatment of bio-synthesized extracellular matrix. The investigators then went on to cull key peptides and, from these, they created the peptide, comb1, possessing several strategic features, including its ability to stimulate angiogenesis by increasing blood vessel growth by 200% in vitro.

The second wound-healing peptide, UN3, identified in the current study, was created and modified from two naturally occurring peptides that are normally present in trace amounts and found in human platelet-rich plasma.

"The confirmation that these peptides could act synergistically to improve human wound healing moves our research one significant step closer to clinical application. We hope that someday soon, we may be able to help transform the way in which wound care is being delivered in civilian and combat settings," said Ira Herman, PhD, professor of molecular physiology and pharmacology at Tufts University School of Medicine. Professor Herman is director, molecular and cellular physiology graduate program at the Sackler School of Graduate Biomedical Sciences and director, Center for Innovations in Wound Healing Research, Tufts University.

"The wound-healing peptides should also prove strategic as we continue developing 'smart' devices or fully-vascularized living tissue constructs for burn patients or those patients suffering with diabetic plantar or venous stasis ulcers. Clinical trials using the peptides will be the next step," Herman continued. Tufts University has filed patent applications related to the wound-healing peptides.

Tufts Center for Innovations in Wound Healing Research brings together experts from Tufts' medical, dental, veterinary and engineering schools, as well as Tufts Medical Center and local research institutes with a focus on creating innovative wound healing therapeutics as well as fully-vascularized organ constructs for personalized regenerative medicine.

Demidova-Rice is now at the Edwin L. Steele Laboratory for Tumor Biology in the department of Radiation Oncology at Massachusetts General Hospital. Additional authors include Lindsey Wolf, BS, formerly a research assistant at TUSM, now a graduate student working towards a PhD degree in the department of molecular genetics and microbiology at the University of Texas at Austin; Jeffry Deckenback, PhD, who was a postdoctoral fellow in the Herman lab while the work was being carried out; and Michael R. Hamblin, PhD, a principal investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital and associate professor in the department of dermatology at Harvard Medical School.

###

This research was supported in part by grants # EY15125 and # EY19533 from the National Eye Institute, part of the National Institutes of Health, and Wound Care Partners, LLC.

Demidova-Rice TN, Wolf L, Deckenback J, Hamblin MR, Herman IM. PLoS ONE. "Human Platelet-Rich Plasma- and Extracellular Matrix-Derived Peptides Promote Impaired Cutaneous Would Healing In Vivo." Published February 23, 2012, doi:10.1371/journal.pone.0032146.

About Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences

Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts University are international leaders in innovative medical education and advanced research. The School of Medicine and the Sackler School are renowned for excellence in education in general medicine, biomedical sciences, special combined degree programs in business, health management, public health, bioengineering and international relations, as well as basic and clinical research at the cellular and molecular level. Ranked among the top in the nation, the School of Medicine is affiliated with six major teaching hospitals and more than 30 health care facilities. Tufts University School of Medicine and the Sackler School undertake research that is consistently rated among the highest in the nation for its effect on the advancement of medical science.

If you are a member of the media interested in learning more about this topic, or speaking with a faculty member at the Tufts University School of Medicine or another Tufts health sciences researcher, please contact Siobhan Gallagher at 617-636-6586.

END



ELSE PRESS RELEASES FROM THIS DATE:

New theory shows that neither birth nor death stops a flock

New theory shows that neither birth nor death stops a flock
2012-02-27
EUGENE, Ore. -- (Feb. 24, 2011) -- Neither births nor deaths stop the flocking of organisms. They just keep moving, says theoretical physicist John J. Toner of the University of Oregon. The notion, he says, has implications in biology and eventually could point to new cancer therapies. Picture any scenario in which self-propelled organisms -- animals, birds, bacteria, molecules within cells, cancer cells, fish, and even tiny plastic rods on a vibrating table -- move as a swarm or flock in the same direction. Eighteen years ago, Toner co-developed two equations that together ...

Could rosemary scent boost brain performance?

2012-02-27
Hailed since ancient times for its medicinal properties, we still have a lot to learn about the effects of rosemary. Now researchers writing in Therapeutic Advances in Psychopharmacology, published by SAGE, have shown for the first time that blood levels of a rosemary oil component correlate with improved cognitive performance. Rosemary (Rosmarinus officinalis) is one of many traditional medicinal plants that yield essential oils. But exactly how such plants affect human behaviour is still unclear. Mark Moss and Lorraine Oliver, working at the Brain, Performance and Nutrition ...

Combined inhibition of VEGF and c-MET can decrease metastasis

2012-02-27
Inhibition of VEGF increased c-MET expression in tumors. Invasion and metastasis were blocked by inhibition of VEGF plus c-MET. Dual VEGF/c-MET inhibitors are in late-stage clinical trials. PHILADELPHIA — Dual inhibition of vascular endothelial growth factor and c-MET signaling inhibited tumor invasion and metastasis in a laboratory model of pancreatic neuroendocrine cancer, according to a paper published in Cancer Discovery, the newest journal of the American Association for Cancer Research. "Inhibition of VEGF signaling plus c-MET signaling results in a synergistic ...

Cancer therapy more potent when it hits 2 targets

Cancer therapy more potent when it hits 2 targets
2012-02-27
Simultaneous targeting of two different molecules in cancer is an effective way to shrink tumors, block invasion, and stop metastasis, scientists at the University of California, San Francisco (UCSF) have found—work that may improve the effectiveness of combination treatments that include drugs like Avastin. The two-target approach, tested in mice with a type of cancer known as neuroendocrine pancreatic tumors, may have broad application for treating a wide variety of cancers, the UCSF team said. The drugs used in the tests belong to classes of pharmaceuticals that are ...

Grateful Dead Tribute Band Brother Esau Announces New Partnership With EastCoast Entertainment Agency

2012-02-27
Brother Esau a Grateful Dead Tribute Band, officially announced it's partnership with EastCoast Entertainment to represent them for their night club, corporate event, private party and concert bookings. Brother Esau is a Grateful Dead Tribute Band that celebrates the Grateful Dead's music and recaptures the mystique of the iconic band. The band has become a fixture in the Raleigh, Chapel Hill and the Greensboro, NC's Jam Band scene, often collaborating with some of the areas finest musicians. Venues played include The Cat's Cradle in Chapel Hill, NC, The Blind Tiger ...

NESTA Offers More Local Fitness Workshops for Personal Fitness Trainers in 2012

2012-02-27
Already recognized for its global online personal training programs and certification, the National Exercise & Sports Trainers Association (NESTA) recently expanded its local, personal training workshops from coast to coast. As a supplement to its online programs, the personal training workshops, provided by Training Made Fun, are now available in Arizona, California, Florida, Hawaii, Kansas, Nevada, New Jersey, New York, Oregon, Utah and Washington. The two-day personal training workshops offer the NESTA Personal Fitness Training certification, which is accredited ...

California Autobody Association Proudly Announces the Election of Dave Picton as Association President for 2012

California Autobody Association Proudly Announces the Election of Dave Picton as Association President for 2012
2012-02-27
The California Autobody Association (CAA) announced today the election of Dave Picton, owner of G&R Body and Paint, located in Sacramento, as the association president for the 2012 fiscal year. As president, Mr. Picton has overall responsibility for leading the CAA, and has a busy agenda set for the year. "We are extremely excited to have Dave as the president of our association," said Dave McClune, the executive director of the CAA. "His industry experience, dedication to the growth and success of our membership, and commitment to furthering our legislative ...

HollywoodSportsbook.com Welcomes National Cheerleader Week

2012-02-27
Hollywoodsportsbook (www.hollywoodsportsbook.com) a leading online entertainment gaming site since 1997, today announced that it is celebrating National Cheerleader Week by offering its clients personalized private photos of their in house cheerleading team, known as The Hollywood Hotties. Robert Evans, Hollywood's Director of Operations says, "we know what boys like, we know what boys want...Cheerleaders!..so we are giving them personalized pictures of our in house cheerleading squad, the infamous Hollywood Hotties. We also offer a fun video on our site for our ...

Wrigleyville Sports Announces Further Expansion of Wrigleyville Store, in Time for Upcoming Cubs Season

2012-02-27
Wrigleyville Sports, an official retailer of Chicago Cubs merchandise, is excited to announce it will be expanding its store (959 W Addison) located across the street from historic Wrigley Field, in Chicago. The retailer underwent an expansion in the Spring of 2010, nearly doubling their browsing area. With the recent acquisition of the former location of Sitclose Tickets, the store will continue its growth eastward, towards the Addison Red Line stop. "The store has always tried to carry everything, and more, for the Chicago Cub fan, but with the resurgence in other ...

New knowledge on the pharmacology of dopamine stabilizers

2012-02-27
A study from Karolinska Institutet in Sweden shows that a new drug for Huntington's disease – pridopidine or dopamine stabiliser ACR16 – might operate via previously unknown mechanisms of action. Researchers have found that at very low concentrations, ACR16 binds to the sigma-1 receptor, a protein in the brain important to neuronal function and survival. This new knowledge can be used to develop future treatments for schizophrenia, involuntary Parkinsonian tremors and neurodegenerative diseases. "It's conceivable that some of the beneficial effects of dopamine stabilisers ...

LAST 30 PRESS RELEASES:

A new chapter in Roman administration: Insights from a late Roman inscription

Global trust in science remains strong

New global research reveals strong public trust in science

Inflammation may explain stomach problems in psoriasis sufferers

Guidance on animal-borne infections in the Canadian Arctic

Fatty muscles raise the risk of serious heart disease regardless of overall body weight

HKU ecologists uncover significant ecological impact of hybrid grouper release through religious practices

New register opens to crown Champion Trees across the U.S.

A unified approach to health data exchange

New superconductor with hallmark of unconventional superconductivity discovered

Global HIV study finds that cardiovascular risk models underestimate for key populations

New study offers insights into how populations conform or go against the crowd

Development of a high-performance AI device utilizing ion-controlled spin wave interference in magnetic materials

WashU researchers map individual brain dynamics

Technology for oxidizing atmospheric methane won’t help the climate

US Department of Energy announces Early Career Research Program for FY 2025

PECASE winners: 3 UVA engineering professors receive presidential early career awards

‘Turn on the lights’: DAVD display helps navy divers navigate undersea conditions

MSU researcher’s breakthrough model sheds light on solar storms and space weather

Nebraska psychology professor recognized with Presidential Early Career Award

New data shows how ‘rage giving’ boosted immigrant-serving nonprofits during the first Trump Administration

Unique characteristics of a rare liver cancer identified as clinical trial of new treatment begins

From lab to field: CABBI pipeline delivers oil-rich sorghum

Stem cell therapy jumpstarts brain recovery after stroke

Polymer editing can upcycle waste into higher-performance plastics

Research on past hurricanes aims to reduce future risk

UT Health San Antonio, UTSA researchers receive prestigious 2025 Hill Prizes for medicine and technology

Panorama of our nearest galactic neighbor unveils hundreds of millions of stars

A chain reaction: HIV vaccines can lead to antibodies against antibodies

Bacteria in polymers form cables that grow into living gels

[Press-News.org] Novel bioactive peptides promote wound healing in vivo